Credit Suisse’s iShares Biotechnology ETF IBB Stock Holding History

Credit Suisse’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$728K	Sell	5,307 -526	-9%	-$71.8K	﹤0.01%	2455
2023 Q4	$792K	Sell	5,833 -3,351	-36%	-$409K	﹤0.01%	2483
2023 Q3	$1.12M	Buy	9,184 +1,487	+19%	+$189K	﹤0.01%	2231
2023 Q2	$977K	Buy	7,697 +6,066	+372%	+$788K	﹤0.01%	2392
2023 Q1	$211K	Sell	1,631 -18,644	-92%	-$2.44M	﹤0.01%	3104
2022 Q4	$2.66M	Sell	20,275 -28,966	-59%	-$3.74M	﹤0.01%	1720
2022 Q3	$5.85M	Buy	49,241 +13,777	+39%	+$1.71M	0.01%	1170
2022 Q2	$4.21M	Buy	35,464 +25,595	+259%	+$3.04M	﹤0.01%	1399
2022 Q1	$1.29M	Buy	9,869 +8,952	+976%	+$1.17M	﹤0.01%	2375
2021 Q4	$140K	Sell	917 -3,518	-79%	-$545K	﹤0.01%	4342
2021 Q3	$718K	Sell	4,435 -3,172	-42%	-$534K	﹤0.01%	3572
2021 Q2	$1.25M	Sell	7,607 -29,554	-80%	-$4.55M	﹤0.01%	3216
2021 Q1	$5.59M	Sell	37,161 -5,589	-13%	-$888K	﹤0.01%	1987
2020 Q4	$6.48M	Sell	42,750 -6,059	-12%	-$866K	﹤0.01%	1893
2020 Q3	$6.61M	Sell	48,809 -439	-0.9%	-$59.6K	﹤0.01%	1619
2020 Q2	$6.73M	Sell	49,248 -15,211	-24%	-$1.94M	﹤0.01%	1523
2020 Q1	$6.94M	Buy	64,459 +2,723	+4%	+$314K	0.01%	1359
2019 Q4	$7.44M	Sell	61,736 -41,834	-40%	-$4.67M	0.01%	1593
2019 Q3	$10.3M	Buy	103,570 +51,619	+99%	+$5.4M	0.01%	1292
2019 Q2	$5.67M	Buy	51,951 +15,413	+42%	+$1.64M	0.01%	1673
2019 Q1	$4.08M	Sell	36,538 -68,532	-65%	-$7.52M	﹤0.01%	1878
2018 Q4	$10.1M	Sell	105,070 -119,712	-53%	-$12.7M	0.01%	1144
2018 Q3	$27.4M	Buy	224,782 +207,866	+1,229%	+$24.5M	0.02%	710
2018 Q2	$1.86M	Sell	16,916 -8,258	-33%	-$883K	﹤0.01%	2530
2018 Q1	$2.69M	Buy	25,174 +9,775	+63%	+$1.08M	﹤0.01%	2186
2017 Q4	$1.65M	Sell	15,399 -122,091	-89%	-$13.1M	﹤0.01%	2599
2017 Q3	$15.3M	Sell	137,490 -132,984	-49%	-$14.2M	0.01%	991
2017 Q2	$28M	Sell	270,474 -1,077,867	-80%	-$106M	0.03%	645
2017 Q1	$132M	Buy	1,348,341 +707,856	+111%	+$67.8M	0.12%	162
2016 Q4	$56.7M	Buy	640,485 +37,965	+6%	+$3.46M	0.06%	352
2016 Q3	$58.1M	Buy	602,520 +279,420	+86%	+$26.6M	0.06%	373
2016 Q2	$27.7M	Buy	323,100 +275,028	+572%	+$24.7M	0.03%	615
2016 Q1	$4.18M	Sell	48,072 -57,222	-54%	-$5.12M	0.01%	1654
2015 Q4	$11.9M	Sell	105,294 -3,274,626	-97%	-$355M	0.01%	1055
2015 Q3	$342M	Buy	3,379,920 +3,145,281	+1,340%	+$377M	0.41%	37
2015 Q2	$28.9M	Buy	234,639 +61,440	+35%	+$7.35M	0.03%	645
2015 Q1	$19.8M	Sell	173,199 -1,243,923	-88%	-$137M	0.02%	821
2014 Q4	$143M	Sell	1,417,122 -147,363	-9%	-$14.3M	0.13%	162
2014 Q3	$143M	Buy	1,564,485 +252,300	+19%	+$22.1M	0.12%	165
2014 Q2	$112M	Buy	1,312,185 +93,048	+8%	+$7.33M	0.09%	203
2014 Q1	$96.1M	Buy	1,219,137 +1,120,731	+1,139%	+$93.4M	0.09%	206
2013 Q4	$7.45M	Buy	98,406 +85,353	+654%	+$6.06M	0.01%	1491
2013 Q3	$912K	Sell	13,053 -813,357	-98%	-$53.3M	﹤0.01%	3042
2013 Q2	$47.9M	Buy	+826,410	New	+$47.8M	0.05%	386

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Credit Suisse's IBB Position: Q1 2024 in Review

Credit Suisse reduced its iShares Biotechnology ETF (IBB) stake by 9% in Q1 2024, selling an estimated $71.8K and leaving 5,307 shares worth $728K. The position accounts for ﹤0.01% of the portfolio, ranked #2455.

Credit Suisse first reported a position in IBB in Q2 2013 and has held it in 44 quarters since. The position peaked at $342M in Q3 2015. 899 funds tracked by Wall St. Rank hold IBB as of Q1 2024.

Credit Suisse held 5,307 shares of iShares Biotechnology ETF worth $728K as of Q1 2024.
Credit Suisse sold 526 iShares Biotechnology ETF shares in Q1 2024, an estimated $71.8K.
iShares Biotechnology ETF made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #2455 holding.
Credit Suisse first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 44 quarters since.
Credit Suisse's iShares Biotechnology ETF position peaked at $342M in Q3 2015.
899 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.